menu
    • menu

    Company profile for Halozyme Therapeutics

    NEW Drugs in Dev: 24
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise th...
    Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise that allows us to pursue this target-rich environment for the development of future therapies. The company's research focuses primarily on human enzymes that alter the extracellular matrix.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Halozyme TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11388 Sorrento Valley Road San Diego, CA 92121
    Telephone
    Telephone
    858.794.8889
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://halozyme.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Halozyme Reiterates 2026 Financial Guidance After Q1 Results
    Halozyme Reiterates 2026 Financial Guidance After Q1 Results

    11 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-reports-first-quarter-2026-results-and-reiterates-2026-financial-guidance-302768578.html

    PR NEWSWIRE
    11 May 2026
    Share Share
    GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs
    GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-announces-global-collaboration-and-license-agreement-with-gsk-to-develop-subcutaneous-formulations-of-multiple-promising-oncology-targets-302765632.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Halozyme To Report Q1 2026 Financial And Operating Results
    Halozyme To Report Q1 2026 Financial And Operating Results

    01 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-to-report-first-quarter-2026-financial-and-operating-results-302759415.html

    PR NEWSWIRE
    01 May 2026
    Share Share
    Halozyme Appoints Darren Snellgrove As Chief Financial Officer
    Halozyme Appoints Darren Snellgrove As Chief Financial Officer

    30 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-appoints-darren-snellgrove-as-chief-financial-officer-302758516.html

    PR NEWSWIRE
    30 Apr 2026
    Share Share
    Vertex Taps Halozyme In $15M Upfront Biologics Drug Delivery Deal
    Vertex Taps Halozyme In $15M Upfront Biologics Drug Delivery Deal

    07 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/vertex-taps-halozyme-and-its-recently-acquired-elektrofi-tech-15m-drug-delivery-deal

    FIERCE PHARMA
    07 Apr 2026
    Share Share
    Halozyme, Vertex Pharma Partner on Hypercon Technology
    Halozyme, Vertex Pharma Partner on Hypercon Technology

    07 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-announces-global-collaboration-and-license-agreement-with-vertex-pharmaceuticals-for-hypercon-technology-302735490.html

    PR NEWSWIRE
    07 Apr 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Halozyme Therapeutics and get a quotation

    Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search